We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.
De Carolis, S., Rizzo, F., Tabacco, S., Hydroxychloroquine as additional treatment in pregnant patients with refractory APS, <<AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY>>, 2017; 217 (6): 711-712. [doi:10.1016/j.ajog.2017.08.113] [http://hdl.handle.net/10807/112090]
Hydroxychloroquine as additional treatment in pregnant patients with refractory APS
De Carolis, Sara
Primo
;Tabacco, Sara
2017
Abstract
We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
